| Latest | F'cast | |
|---|---|---|
| Div Yield | 8.6% | |
| Div Cover | 0.9 | |
| Op Mrgn | 7.7% | |
| ROCE | 13.2% |
| Latest | F'cast | |
|---|---|---|
| P/E | 13.3 | |
| PEG | n/a | |
| Pr/Revenue | 0.6 | |
| Pr/Book | 2.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -14.8% | |
| PBT | n/a | |
| EPS | n/a | |
| DPS | n/a |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 9,714.00 | (844.00) | (1,090.00)¢ | n/a | n/a | n/a | 262.00¢ | 2.7% |
| 31-Dec-21 | 11,434.00 | 1,094.00 | 915.00¢ | 11.2 | n/a | n/a | 385.00¢ | 3.8% |
| 31-Dec-22 | 7,979.00 | 1,132.00 | 858.00¢ | 11.0 | n/a | -6% | 405.00¢ | 4.3% |
| 31-Dec-23 | 6,024.00 | (28.00) | (36.00)¢ | n/a | n/a | n/a | 243.00¢ | 8.8% |
| 31-Dec-24 | 5,130.00 | 233.00 | 212.00¢ | 14.7 | n/a | n/a | 243.00¢ | 7.8% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 4,418.32 | 563.29 | 320.36¢ | 8.8 | 0.2 | +51% | 242.89¢ | 0.0% |
| 31-Dec-26 | 4,515.92 | 572.77 | 348.66¢ | 8.1 | 0.9 | +9% | 242.43¢ | 0.0% |
| 31-Dec-27 | 4,663.14 | 652.05 | 373.96¢ | 7.5 | 1.0 | +7% | 245.84¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Boeing suppliers hit by 737 MAX suspension | 17-Dec-2019 | ShareCast |
| Business Briefing | 29-Sep-2009 | LA Times |
| Abbott buys Belgian drug unit for $6.6B | 29-Sep-2009 | Wall Street Journal |
| Abbott buys Solvay pharma operations for $6.6 bi... | 29-Sep-2009 | LA Times |
| Currency | Euro |
| Share Price | 28.33 |
| Change Today | 0.21 |
| % Change | 0.74 % |
| 52 Week High | 38.68 |
| 52 Week Low | 26.24 |
| Volume | 75,224 |
| Shares Issued | 105.00m |
| Market Cap | 2,974.44m |
| Beta | 0.75 |
| Strong Buy | 3 |
| Buy | 3 |
| Neutral | 6 |
| Sell | 3 |
| Strong Sell | 1 |
| Total | 16 |

| Time | Volume / Share Price |
| 11:55 | 139 @ 28.34 |
| 11:54 | 2 @ 28.36 |
| 11:54 | 111 @ 28.36 |
| 11:54 | 84 @ 28.36 |
| 11:54 | 64 @ 28.36 |
You are here: research